Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)
80.92
+2.17 (2.76%)
Apr 1, 2025, 2:45 PM CST
SHE:002821 Revenue
In the year 2024, Asymchem Laboratories (Tianjin) had annual revenue of 5.80B CNY, down -25.82%. Asymchem Laboratories (Tianjin) had revenue of 1.66B in the quarter ending December 31, 2024, with 15.41% growth.
Revenue
5.80B
Revenue Growth
-25.82%
P/S Ratio
4.93
Revenue / Employee
604.97K
Employees
9,788
Market Cap
28.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.80B | -2.02B | -25.82% |
Dec 31, 2023 | 7.83B | -2.43B | -23.70% |
Jan 1, 2023 | 10.26B | 5.62B | 121.40% |
Dec 31, 2021 | 4.63B | 1.50B | 47.67% |
Dec 31, 2020 | 3.14B | 676.74M | 27.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |